Hepatocellular Carcinoma Cases with High Levels of C-Raf-1 Expression May Benefit from Postoperative Adjuvant Sorafenib after Hepatic Resection Even with High Risk of Recurrence.
Oncotarget（2016）
关键词
hepatocellular carcinoma,recurrence,sorafenib,risk factors,liver resection
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要